Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
McKesson
Baxter
Medtronic
AstraZeneca
Harvard Business School

Last Updated: November 29, 2021

DrugPatentWatch Database Preview

Patent: 8,729,027

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 8,729,027
Title:Therapeutic agent for fibromyalgia containing etanercept
Abstract: Disclosed is a drug effective in the treatment of fibromyalgia. Basically, the disclosed therapeutic agent was created on the basis of experiments showing improvement in symptoms when etanercept was administered to patients suffering from fibromyalgia. Etanercept is known as a therapeutic agent for rheumatoid arthritis, and the JFIQ score of patients not suffering from fibromyalgia improved considerably in the preferred embodiment. In other words, a therapeutic agent for fibromyalgia is disclosed that contains etanercept as an active ingredient in an effective amount.
Inventor(s): Nishioka; Kusuki (Tokyo, JP)
Assignee: AXIS Inc. (Kagoshima, JP)
Application Number:13/808,291
Patent Claims:see list of patent claims

Details for Patent 8,729,027

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Immunex Corporation ENBREL etanercept For Injection 103795 1998-11-02 ⤷  Try it Free 2030-07-05
Immunex Corporation ENBREL etanercept For Injection 103795 1999-05-27 ⤷  Try it Free 2030-07-05
Immunex Corporation ENBREL etanercept Injection 103795 2004-09-27 ⤷  Try it Free 2030-07-05
Immunex Corporation ENBREL etanercept Injection 103795 2007-02-01 ⤷  Try it Free 2030-07-05
Immunex Corporation ENBREL MINI etanercept Injection 103795 2017-09-14 ⤷  Try it Free 2030-07-05
Immunex Corporation ENBREL etanercept Injection 103795 ⤷  Try it Free 2030-07-05
Immunex Corporation ENBREL etanercept Injection 103795 2020-03-05 ⤷  Try it Free 2030-07-05
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
Baxter
Harvard Business School
McKesson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.